Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New help/navigation items were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and a merged Intervention/Treatment header. The older Intervention / Treatment label and the Revision: v3.5.5 note were removed, and the revision label updated to Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:42:21.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new Revision: v3.5.5 label was added, replacing the previous Revision: v3.5.4. This indicates a newer site revision label in the page's documentation area.
    Difference
    0.1%
    Check dated 2026-06-07T02:25:36.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.5.4 now appears, replacing the previous v3.5.3. The update denotes a minor version bump to the page and its linked documents.
    Difference
    0.1%
    Check dated 2026-05-16T09:19:51.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an internal site release rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T17:14:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; previous revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T14:11:14.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added a related term for head and neck squamous cell carcinoma and a new Resources link to the Genetic and Rare Diseases Information Center on the study page.
    Difference
    0.2%
    Check dated 2026-04-03T06:07:41.000Z thumbnail image

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.